Skip to main content

Table 1 Comparison between the 3 groups as regards pre-operative data using Kruskal–Wallis test

From: The effect of short-term use of finasteride versus cyproterone acetate on perioperative blood loss with monopolar transurethral resection of prostate

Variable

CPA group (20)

Finasteride group (20)

Control group (20)

Kruskal–Wallis Test

Median (IQR)

Median (IQR)

Median (IQR)

P value

Age (years)

68.5 (65 – 71.5)

69.5 (66 – 71.5)

66 (63 – 70.5)

 = 0.4647

Prostate size (cm3)

78.5 (71 – 89)

73.5 (69 – 84)

76.5 (69 – 85)

 = 0.4937

PVRU (ml)

225 (146 – 292.5)

200 (165 – 253)

211 (195 – 285)

 = 0.6869

IPSS

28.5 (24 – 30)

27.5 (25 – 28.5)

26.5 (22.5 – 28)

 = 0.2545

Q max

7 (5.7 – 8)

7 (6.2 – 8)

7 (6.7 – 8)

 = 0.6526

Hb (g/dL)

14 (13.1 – 14)

13.8 (13 – 14.2)

14 (13.8 – 14.5)

 = 0.3281

HCT (%)

44.5 (44 – 45)

44.4 (43 – 45)

44.8 (44 – 45)

 = 0.6044

PSA (ng/dL)

2.8 (2.1 – 3.6)

3 (2.5 – 3.8)

3.1 (2.2 – 3.8)

 = 0.6768